Package 54288-142-25

Brand: papaverine hydrochloride

Generic: papaverine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 54288-142-25
Digits Only 5428814225
Product NDC 54288-142
Product ID 54288-142_afdd82fd-269d-4d51-b3f1-515ce7ead96d
Description

25 VIAL in 1 CARTON (54288-142-25) / 2 mL in 1 VIAL (54288-142-01)

Marketing

Marketing Status
Marketed Since 2023-04-26
Brand papaverine hydrochloride
Generic papaverine hydrochloride
Sample Package No

Linked Drug Pages (1)

PAPAVERINE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "PARENTERAL"], "spl_id": "afdd82fd-269d-4d51-b3f1-515ce7ead96d", "openfda": {"upc": ["0354288142250", "0354288142106"], "unii": ["23473EC6BQ"], "rxcui": ["1789947"], "spl_set_id": ["6f16f2ed-8e1c-4c6f-bd1d-846e02b1be97"], "manufacturer_name": ["BPI Labs LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (54288-142-10)  / 2 mL in 1 VIAL (54288-142-01)", "package_ndc": "54288-142-10", "marketing_start_date": "20210710"}, {"sample": false, "description": "25 VIAL in 1 CARTON (54288-142-25)  / 2 mL in 1 VIAL (54288-142-01)", "package_ndc": "54288-142-25", "marketing_start_date": "20230426"}], "brand_name": "PAPAVERINE HYDROCHLORIDE", "product_id": "54288-142_afdd82fd-269d-4d51-b3f1-515ce7ead96d", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "54288-142", "generic_name": "Papaverine Hydrochloride", "labeler_name": "BPI Labs LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PAPAVERINE HYDROCHLORIDE", "active_ingredients": [{"name": "PAPAVERINE HYDROCHLORIDE", "strength": "30 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20210710", "listing_expiration_date": "20261231"}